Pre-order Enquiry
Request Free Sample
Global Plasma-derived Factor VIII Market Insights, Forecast to 2025
SKU ID : QYR-14104536 | Publishing Date : 15-Apr-2019 | No. of pages : 118
Detailed TOC of Global Plasma-derived Factor VIII Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Plasma-derived Factor VIII Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Plasma-derived Factor VIII Market Size Growth Rate by Product
1.4.2 200IU
1.4.3 250IU
1.5 Market by End User
1.5.1 Global Plasma-derived Factor VIII Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Factor VIII Market Size
2.1.1 Global Plasma-derived Factor VIII Revenue 2014-2025
2.1.2 Global Plasma-derived Factor VIII Sales 2014-2025
2.2 Plasma-derived Factor VIII Growth Rate by Regions
2.2.1 Global Plasma-derived Factor VIII Sales by Regions
2.2.2 Global Plasma-derived Factor VIII Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Plasma-derived Factor VIII Sales by Manufacturers
3.1.1 Plasma-derived Factor VIII Sales by Manufacturers
3.1.2 Plasma-derived Factor VIII Sales Market Share by Manufacturers
3.1.3 Global Plasma-derived Factor VIII Market Concentration Ratio (CR5 and HHI)
3.2 Plasma-derived Factor VIII Revenue by Manufacturers
3.2.1 Plasma-derived Factor VIII Revenue by Manufacturers (2014-2019)
3.2.2 Plasma-derived Factor VIII Revenue Share by Manufacturers (2014-2019)
3.3 Plasma-derived Factor VIII Price by Manufacturers
3.4 Plasma-derived Factor VIII Manufacturing Base Distribution, Product Types
3.4.1 Plasma-derived Factor VIII Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasma-derived Factor VIII Product Type
3.4.3 Date of International Manufacturers Enter into Plasma-derived Factor VIII Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Plasma-derived Factor VIII Sales by Product
4.2 Global Plasma-derived Factor VIII Revenue by Product
4.3 Plasma-derived Factor VIII Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Plasma-derived Factor VIII Breakdown Data by End User
6 North America
6.1 North America Plasma-derived Factor VIII by Countries
6.1.1 North America Plasma-derived Factor VIII Sales by Countries
6.1.2 North America Plasma-derived Factor VIII Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Plasma-derived Factor VIII by Product
6.3 North America Plasma-derived Factor VIII by End User
7 Europe
7.1 Europe Plasma-derived Factor VIII by Countries
7.1.1 Europe Plasma-derived Factor VIII Sales by Countries
7.1.2 Europe Plasma-derived Factor VIII Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Plasma-derived Factor VIII by Product
7.3 Europe Plasma-derived Factor VIII by End User
8 Asia Pacific
8.1 Asia Pacific Plasma-derived Factor VIII by Countries
8.1.1 Asia Pacific Plasma-derived Factor VIII Sales by Countries
8.1.2 Asia Pacific Plasma-derived Factor VIII Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Plasma-derived Factor VIII by Product
8.3 Asia Pacific Plasma-derived Factor VIII by End User
9 Central & South America
9.1 Central & South America Plasma-derived Factor VIII by Countries
9.1.1 Central & South America Plasma-derived Factor VIII Sales by Countries
9.1.2 Central & South America Plasma-derived Factor VIII Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Plasma-derived Factor VIII by Product
9.3 Central & South America Plasma-derived Factor VIII by End User
10 Middle East and Africa
10.1 Middle East and Africa Plasma-derived Factor VIII by Countries
10.1.1 Middle East and Africa Plasma-derived Factor VIII Sales by Countries
10.1.2 Middle East and Africa Plasma-derived Factor VIII Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Plasma-derived Factor VIII by Product
10.3 Middle East and Africa Plasma-derived Factor VIII by End User
11 Company Profiles
11.1 Shire (Baxter)
11.1.1 Shire (Baxter) Company Details
11.1.2 Company Business Overview
11.1.3 Shire (Baxter) Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Shire (Baxter) Plasma-derived Factor VIII Products Offered
11.1.5 Shire (Baxter) Recent Development
11.2 Octapharma
11.2.1 Octapharma Company Details
11.2.2 Company Business Overview
11.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Octapharma Plasma-derived Factor VIII Products Offered
11.2.5 Octapharma Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 Company Business Overview
11.3.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.3.4 CSL Plasma-derived Factor VIII Products Offered
11.3.5 CSL Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Company Business Overview
11.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Grifols Plasma-derived Factor VIII Products Offered
11.4.5 Grifols Recent Development
11.5 Greencross
11.5.1 Greencross Company Details
11.5.2 Company Business Overview
11.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Greencross Plasma-derived Factor VIII Products Offered
11.5.5 Greencross Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Company Business Overview
11.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Kedrion Plasma-derived Factor VIII Products Offered
11.6.5 Kedrion Recent Development
11.7 BPL
11.7.1 BPL Company Details
11.7.2 Company Business Overview
11.7.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.7.4 BPL Plasma-derived Factor VIII Products Offered
11.7.5 BPL Recent Development
11.8 Hualan Bio
11.8.1 Hualan Bio Company Details
11.8.2 Company Business Overview
11.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Hualan Bio Plasma-derived Factor VIII Products Offered
11.8.5 Hualan Bio Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 Company Business Overview
11.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2014-2019)
11.9.4 RAAS Plasma-derived Factor VIII Products Offered
11.9.5 RAAS Recent Development
12 Future Forecast
12.1 Plasma-derived Factor VIII Market Forecast by Regions
12.1.1 Global Plasma-derived Factor VIII Sales Forecast by Regions 2019-2025
12.1.2 Global Plasma-derived Factor VIII Revenue Forecast by Regions 2019-2025
12.2 Plasma-derived Factor VIII Market Forecast by Product
12.2.1 Global Plasma-derived Factor VIII Sales Forecast by Product 2019-2025
12.2.2 Global Plasma-derived Factor VIII Revenue Forecast by Product 2019-2025
12.3 Plasma-derived Factor VIII Market Forecast by End User
12.4 North America Plasma-derived Factor VIII Forecast
12.5 Europe Plasma-derived Factor VIII Forecast
12.6 Asia Pacific Plasma-derived Factor VIII Forecast
12.7 Central & South America Plasma-derived Factor VIII Forecast
12.8 Middle East and Africa Plasma-derived Factor VIII Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Plasma-derived Factor VIII Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Plasma-derived Factor VIII Market Insights, Forecast to 2025
List of Tables and FiguresFigure Plasma-derived Factor VIII Product Picture
Table Plasma-derived Factor VIII Market Segments
Table Key Manufacturers Plasma-derived Factor VIII Covered
Table Global Plasma-derived Factor VIII Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Plasma-derived Factor VIII Sales Market Share by Product 2014-2025
Figure 200IU Product Picture
Table Major Manufacturers of 200IU
Figure 250IU Product Picture
Table Major Manufacturers of 250IU
Table Global Plasma-derived Factor VIII Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Pharmacy
Figure Plasma-derived Factor VIII Report Years Considered
Figure Global Plasma-derived Factor VIII Market Size 2014-2025 (Million US$)
Figure Global Plasma-derived Factor VIII Sales 2014-2025 (K Units)
Table Global Plasma-derived Factor VIII Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Plasma-derived Factor VIII Sales by Regions 2014-2019 (K Units)
Table Global Plasma-derived Factor VIII Sales Market Share by Regions 2014-2019
Figure Global Plasma-derived Factor VIII Sales Market Share by Regions 2014-2019
Figure 2018 Global Plasma-derived Factor VIII Sales Market Share by Regions
Table Global Plasma-derived Factor VIII Revenue by Regions 2014-2019 (Million US$)
Table Global Plasma-derived Factor VIII Revenue Market Share by Regions 2014-2019
Figure Global Plasma-derived Factor VIII Revenue Market Share by Regions 2014-2019
Figure 2018 Global Plasma-derived Factor VIII Revenue Market Share by Regions
Table Global Plasma-derived Factor VIII Sales by Manufacturers (2014-2019) (K Units)
Table Global Plasma-derived Factor VIII Sales Share by Manufacturers (2014-2019)
Figure Global Plasma-derived Factor VIII Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Plasma-derived Factor VIII Revenue by Manufacturers (2014-2019) (Million USD)
Table Plasma-derived Factor VIII Revenue Share by Manufacturers (2014-2019)
Figure Plasma-derived Factor VIII Value Share by Manufacturers in 2018
Table Key Manufacturers Plasma-derived Factor VIII Price (2014-2019) (USD/Unit)
Table Plasma-derived Factor VIII Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Plasma-derived Factor VIII Product Type
Table Date of International Manufacturers Enter into Plasma-derived Factor VIII Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table Global Plasma-derived Factor VIII Sales Share by Product (2014-2019)
Figure Global Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure Global Plasma-derived Factor VIII Sales Market Share by Product in 2018
Table Global Plasma-derived Factor VIII Revenue by Product (2014-2019) (Million US$)
Table Global Plasma-derived Factor VIII Revenue Share by Product (2014-2019)
Figure Global Plasma-derived Factor VIII Revenue Market Share by Product (2014-2019)
Figure Global Plasma-derived Factor VIII Revenue Market Share by Product in 2018
Table Plasma-derived Factor VIII Price by Product 2014-2019 (USD/Unit)
Table Global Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table Global Plasma-derived Factor VIII Sales Share by End User (2014-2019)
Figure Global Sales Plasma-derived Factor VIII Market Share by End User (2014-2019)
Figure Global Sales Plasma-derived Factor VIII Market Share by End User in 2018
Figure North America Plasma-derived Factor VIII Sales Growth Rate 2014-2019 (K Units)
Figure North America Plasma-derived Factor VIII Revenue Growth Rate 2014-2019 (Million US$)
Table North America Plasma-derived Factor VIII Sales by Countries (2014-2019) (K Units)
Table North America Plasma-derived Factor VIII Sales Market Share by Countries (2014-2019)
Figure 2018 North America Plasma-derived Factor VIII Sales Market Share by Countries
Table North America Plasma-derived Factor VIII Revenue by Countries (2014-2019) (Million US$)
Table North America Plasma-derived Factor VIII Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Plasma-derived Factor VIII Revenue Market Share by Countries
Figure United States Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure United States Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Canada Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Table North America Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table North America Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure 2018 North America Plasma-derived Factor VIII Market Share by Product
Table North America Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table North America Plasma-derived Factor VIII Sales Market Share by End User (2014-2019)
Figure 2018 North America Plasma-derived Factor VIII Market Share by End User
Figure Europe Plasma-derived Factor VIII Sales Growth Rate 2014-2019 (K Units)
Figure Europe Plasma-derived Factor VIII Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Plasma-derived Factor VIII Sales by Countries (2014-2019) (K Units)
Table Europe Plasma-derived Factor VIII Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Plasma-derived Factor VIII Sales Market Share by Countries
Table Europe Plasma-derived Factor VIII Revenue by Countries (2014-2019) (Million US$)
Table Europe Plasma-derived Factor VIII Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Plasma-derived Factor VIII Revenue Market Share by Countries
Figure Germany Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Germany Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure France Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure France Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure UK Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Italy Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Russia Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table Europe Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure 2018 Europe Plasma-derived Factor VIII Market Share by Product
Table Europe Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table Europe Plasma-derived Factor VIII Sales Market Share by End User (2014-2019)
Figure 2018 Europe Plasma-derived Factor VIII Market Share by End User
Figure Asia Pacific Plasma-derived Factor VIII Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Plasma-derived Factor VIII Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Plasma-derived Factor VIII Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Plasma-derived Factor VIII Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Plasma-derived Factor VIII Sales Market Share by Countries
Table Asia Pacific Plasma-derived Factor VIII Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Plasma-derived Factor VIII Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Plasma-derived Factor VIII Revenue Market Share by Countries
Figure China Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure China Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Japan Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Korea Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure India Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure India Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Australia Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table Asia Pacific Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Plasma-derived Factor VIII Market Share by Product
Table Asia Pacific Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table Asia Pacific Plasma-derived Factor VIII Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Plasma-derived Factor VIII Market Share by End User
Figure Central & South America Plasma-derived Factor VIII Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Plasma-derived Factor VIII Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Plasma-derived Factor VIII Sales by Countries (2014-2019) (K Units)
Table Central & South America Plasma-derived Factor VIII Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Plasma-derived Factor VIII Sales Market Share by Countries
Table Central & South America Plasma-derived Factor VIII Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Plasma-derived Factor VIII Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Plasma-derived Factor VIII Revenue Market Share by Countries
Figure Brazil Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table Central & South America Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Plasma-derived Factor VIII Market Share by Product
Table Central & South America Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table Central & South America Plasma-derived Factor VIII Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Plasma-derived Factor VIII Market Share by End User
Figure Middle East and Africa Plasma-derived Factor VIII Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Plasma-derived Factor VIII Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Plasma-derived Factor VIII Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Countries
Table Middle East and Africa Plasma-derived Factor VIII Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Plasma-derived Factor VIII Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Plasma-derived Factor VIII Revenue Market Share by Countries
Figure GCC Countries Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Plasma-derived Factor VIII Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Plasma-derived Factor VIII Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Plasma-derived Factor VIII Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Plasma-derived Factor VIII Market Share by Product
Table Middle East and Africa Plasma-derived Factor VIII Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Plasma-derived Factor VIII Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Plasma-derived Factor VIII Market Share by End User
Table Shire (Baxter) Company Details
Table Shire (Baxter) Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire (Baxter) Recent Development
Table Octapharma Company Details
Table Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Octapharma Recent Development
Table CSL Company Details
Table CSL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Recent Development
Table Grifols Company Details
Table Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Grifols Recent Development
Table Greencross Company Details
Table Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Greencross Recent Development
Table Kedrion Company Details
Table Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kedrion Recent Development
Table BPL Company Details
Table BPL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BPL Recent Development
Table Hualan Bio Company Details
Table Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hualan Bio Recent Development
Table RAAS Company Details
Table RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table RAAS Recent Development
Table Global Plasma-derived Factor VIII Sales Forecast by Regions 2019-2025 (K Units)
Table Global Plasma-derived Factor VIII Sales Market Share Forecast by Regions 2019-2025
Table Global Plasma-derived Factor VIII Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Plasma-derived Factor VIII Revenue Market Share Forecast by Regions 2019-2025
Table Global Plasma-derived Factor VIII Sales Forecast by Product 2019-2025 (K Units)
Table Global Plasma-derived Factor VIII Sales Market Share Forecast by Product 2019-2025
Table Global Plasma-derived Factor VIII Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Plasma-derived Factor VIII Revenue Market Share Forecast by Product 2019-2025
Table Global Plasma-derived Factor VIII Sales Forecast by End User 2019-2025 (K Units)
Table Global Plasma-derived Factor VIII Sales Market Share Forecast by End User 2019-2025
Figure North America Plasma-derived Factor VIII Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Plasma-derived Factor VIII Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Plasma-derived Factor VIII Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Plasma-derived Factor VIII Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Plasma-derived Factor VIII Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Plasma-derived Factor VIII Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Plasma-derived Factor VIII Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Plasma-derived Factor VIII Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Plasma-derived Factor VIII Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Plasma-derived Factor VIII Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Plasma-derived Factor VIII Value Chain
Table Plasma-derived Factor VIII Customers List
Table Plasma-derived Factor VIII Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Plasma-derived Factor VIII Market Insights, Forecast to 2025
Shire (Baxter)Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Request Sample
Request Discount
